You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/32768
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSilva, L. B.-
dc.contributor.authorSilva, A. L.-
dc.contributor.authorTraiman, Paulo-
dc.contributor.authorTriginelli, S. A.-
dc.contributor.authorde Lima, C. F.-
dc.contributor.authorSiqueira, C. F.-
dc.contributor.authorBarroso, A.-
dc.contributor.authorRossi, TMFF-
dc.contributor.authorPedrosa, M. S.-
dc.contributor.authorMiranda, D.-
dc.contributor.authorMelo, JRC-
dc.date.accessioned2014-05-20T15:21:39Z-
dc.date.accessioned2016-10-25T17:55:09Z-
dc.date.available2014-05-20T15:21:39Z-
dc.date.available2016-10-25T17:55:09Z-
dc.date.issued2005-05-01-
dc.identifierhttp://dx.doi.org/10.1016/j.ygyno.2005.02.014-
dc.identifier.citationGynecologic Oncology. San Diego: Academic Press Inc. Elsevier B.V., v. 97, n. 2, p. 588-595, 2005.-
dc.identifier.issn0090-8258-
dc.identifier.urihttp://hdl.handle.net/11449/32768-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/32768-
dc.description.abstractObjectives. The aim of this study was to investigate the feasibility of sentinel lymph node (SLN) identification using radioisotopic lymphatic mapping with technetium-99 m-labeled phytate in patients undergoing radical hysterectomy with pelvic lymphadenectomy for treatment of early cervical cancer.Methods. Between July 2001 and February 2003, 56 patients with cervical cancer 1160 stage I (it 53) or stage 11 (it 3) underwent sentinel lymph node detection with preoperative lymphoscintigraphy (Te-99m-labeled phytate injected into the uterine cervix, at 3, 6, 9, and 12 o'clock, at a dose of 55-74 MBq in a volume of 0.8 ml) and intratoperative lymphatic mapping with a handheld gamma probe, Radical hysterectomy was aborted in three cases because parametrial invasion was found intraoperatively and we performed only sentinel node resection. The remaining 53 patients underwent radical hysterectomy with complete pelvic lymphadenectomy, Sentinel nodes were detected using a handheld gamma-probe and removed for pathological assessment during the abdominal radical hysterectomy and pelvic lymphadenectomy.Results. One or more sentinel nodes were detected in 52 out of 56 eligible patients (92.8%). A total of 120 SLNs were detected by lymphoscintigraphy (mean 2.27 nodes per patient) and intraoperatively by gamma probe, Forty-four percent of SLNs were found in the external iliac area, 39% in the obturator region, 8.3% in interiliae region, and 6.7),) in the common iliac area. Unilateral sentinel nodes were found in thirty-one patients (59%). The remaining 21 patients (4100 had bilateral sentinel nodes, Microscopic nodal metastases were confirmed in 17 (32%) cases. In 10 of these patients, only SLNs had metastases. The 98 sentinel node.,, that were negative on hematoxylin and eosin were submitted to cytokeratin immunohistochemical analysis. Five (5.1%) micrometastases were identified with this technique. The sensitivity of the sentinel node was 82.3% (CI 95% - 56.6-96.2) and the negative predictive value was 92.1% (CI 95% 78.6 98.3) the accuracy of sentinel node in predicting the lymph node status was 94.2%,Conclusion. Preoperative lymphoscintigraphy and intraoperative lymphatic mapping with Tc-99-labeled phytate are effective in identifying sentinel nodes in patients undergoing radical hysterectomy and to select women in whom lymph node dissection call be avoided. (c) 2005 Elsevier B.V. All rights reserved.en
dc.format.extent588-595-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.sourceWeb of Science-
dc.subjectcervical cancer sentinel lymph nodept
dc.subjectgamma probept
dc.subjectTc-99m-fitatopt
dc.subjectlymphoscintigraphypt
dc.subjectlymphatic mappingpt
dc.titleSentinel node detection in cervical cancer with Tc-99m-phytateen
dc.typeoutro-
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionEcograf Nucl Med-
dc.contributor.institutionNucl Med Ctr SA-
dc.contributor.institutionMario Penna Hosp-
dc.description.affiliationUniv Fed Minas Gerais, Dept Obstet & Gynecol, BR-30150290 Belo Horizonte, MG, Brazil-
dc.description.affiliationUniv Fed Minas Gerais, Dept Surg, Belo Horizonte, MG, Brazil-
dc.description.affiliationUniv Fed Minas Gerais, Dept Pathol, Belo Horizonte, MG, Brazil-
dc.description.affiliationPaulista State Univ, Dept Obstet & Gynecol, Botucatu, SP, Brazil-
dc.description.affiliationEcograf Nucl Med, Belo Horizonte, MG, Brazil-
dc.description.affiliationNucl Med Ctr SA, Belo Horizonte, MG, Brazil-
dc.description.affiliationMario Penna Hosp, Gynecol Oncol Unit, Belo Horizonte, MG, Brazil-
dc.description.affiliationUnespPaulista State Univ, Dept Obstet & Gynecol, Botucatu, SP, Brazil-
dc.identifier.doi10.1016/j.ygyno.2005.02.014-
dc.identifier.wosWOS:000229231000043-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofGynecologic Oncology-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.